Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma.
Amodio N, Leotta M, Bellizzi D, Di Martino MT, D'Aquila P, Lionetti M, Fabiani F, Leone E, Gullà AM, Passarino G, Caraglia M, Negrini M, Neri A, Giordano A, Tagliaferri P, Tassone P. Amodio N, et al. Among authors: leotta m. Oncotarget. 2012 Oct;3(10):1246-58. doi: 10.18632/oncotarget.675. Oncotarget. 2012. PMID: 23100393 Free PMC article.
miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1.
Amodio N, Di Martino MT, Foresta U, Leone E, Lionetti M, Leotta M, Gullà AM, Pitari MR, Conforti F, Rossi M, Agosti V, Fulciniti M, Misso G, Morabito F, Ferrarini M, Neri A, Caraglia M, Munshi NC, Anderson KC, Tagliaferri P, Tassone P. Amodio N, et al. Among authors: leotta m. Cell Death Dis. 2012 Nov 29;3(11):e436. doi: 10.1038/cddis.2012.175. Cell Death Dis. 2012. PMID: 23190608 Free PMC article.
miR-29b induces SOCS-1 expression by promoter demethylation and negatively regulates migration of multiple myeloma and endothelial cells.
Amodio N, Bellizzi D, Leotta M, Raimondi L, Biamonte L, D'Aquila P, Di Martino MT, Calimeri T, Rossi M, Lionetti M, Leone E, Passarino G, Neri A, Giordano A, Tagliaferri P, Tassone P. Amodio N, et al. Among authors: leotta m. Cell Cycle. 2013 Dec 1;12(23):3650-62. doi: 10.4161/cc.26585. Epub 2013 Sep 25. Cell Cycle. 2013. PMID: 24091729 Free PMC article.
Molecular targets for the treatment of multiple myeloma.
Rossi M, Di Martino MT, Morelli E, Leotta M, Rizzo A, Grimaldi A, Misso G, Tassone P, Caraglia M. Rossi M, et al. Among authors: leotta m. Curr Cancer Drug Targets. 2012 Sep;12(7):757-67. doi: 10.2174/156800912802429300. Curr Cancer Drug Targets. 2012. PMID: 22671925 Review.
Optimal Management for Stage IVB Endometrial Cancer: A Systematic Review.
Capozzi VA, Scarpelli E, De Finis A, Rotondella I, Scebba D, Gallinelli A, Montrucchio C, Martignon G, Leotta M, Ghi T, Berretta R. Capozzi VA, et al. Among authors: leotta m. Cancers (Basel). 2023 Oct 24;15(21):5123. doi: 10.3390/cancers15215123. Cancers (Basel). 2023. PMID: 37958299 Free PMC article. Review.
Lupus Anticoagulant Detection under the Magnifying Glass.
Molinari AC, Martini T, Banov L, Ierardi A, Leotta M, Strangio A, Santoro RC. Molinari AC, et al. Among authors: leotta m. J Clin Med. 2023 Oct 20;12(20):6654. doi: 10.3390/jcm12206654. J Clin Med. 2023. PMID: 37892792 Free PMC article. Review.
23 results